Delivery Order SPE2DU25D5117-SPE2DU26FE573
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,809.62 to AmerisourceBergen Drug Corp on October 21, 2025, for pharmaceutical products and medical supplies under the Pharmaceutical Prime Vendor Division. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency has awarded a delivery order valued at $10,618.69 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed price delivery order, issued on October 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $2,195.94 to AmerisourceBergen Drug Corp on October 23, 2025, under the Pharmaceutical Prime Vendor Global Program contract vehicle. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a child order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency awarded a delivery order valued at $2,812.14 to AmerisourceBergen Drug Corp on October 21, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, with an ultimate completion date of October 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,674.64 by the Defense Logistics Agency's Medical Supply Chain division on October 8, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order calls for pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,481.43 by the Defense Logistics Agency's Medical Supply Chain. The contract, awarded on October 1, 2025, with an ultimate completion date of October 2, 2025, represents a firm fixed-price delivery order under a competitive procurement with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,418.74 to AmerisourceBergen Drug Corp on August 21, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029,532.13 under a firm fixed-price contract by the Defense Logistics Agency's Medical Supply Chain on October 16, 2025, with completion targeted for October 17, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $150,882.31 to AmerisourceBergen Drug Corp on October 20, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is set for completion by October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. The award falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,168.26 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends...
- SPE2DU25D5117Indefinite Delivery Contract
- SPE2DU25D5117-SPE2DU26FE573Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,731.87 to AmerisourceBergen Drug Corp on October 27, 2025, under the Pharmaceutical PV Division contract. This firm fixed-price delivery order, with performance in Conshohocken, Pennsylvania, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems. The company's role under its DLA prime contract encompasses supplying a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, specialty drugs, and medical devices—to support military healthcare programs globally. The Pharmaceutical Prime Vendor Global Program represents a strategic approach by DLA Troop Support to establish multiple regional contracts with different contractors, enabling flexible and comprehensive medical supply support for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/27/25 |